Design, synthesis, and biological evaluation of the N-diarylalkenyl-piperidinecarboxylic acid derivatives as GABA uptake inhibitors (I)

Bioorg Med Chem Lett. 2006 Jan 1;16(1):225-7. doi: 10.1016/j.bmcl.2005.09.004. Epub 2005 Oct 21.

Abstract

Twenty novel N-diarylalkenyl-piperidinecarboxylic acid derivatives were synthesized and evaluated as gamma-aminobutyric acid uptake inhibitors. The biological assay showed that (R)-1-[4,4-bis(3-phenoxymethyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic hydrochloride possessed almost as strong GAT1 inhibitory activity as tiagabine. The synthesis and structure-activity relationships are discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Transport
  • Carboxylic Acids / chemical synthesis
  • Carboxylic Acids / chemistry*
  • Chemistry, Pharmaceutical / methods
  • Drug Design
  • Drug Evaluation, Preclinical
  • GABA Agonists / chemistry
  • GABA Agonists / pharmacology*
  • Humans
  • Inhibitory Concentration 50
  • Models, Chemical
  • Neurons / metabolism
  • Nipecotic Acids / chemistry
  • Nipecotic Acids / pharmacology
  • Pipecolic Acids / chemical synthesis
  • Pipecolic Acids / chemistry*
  • Structure-Activity Relationship
  • Tiagabine
  • gamma-Aminobutyric Acid / metabolism*
  • gamma-Aminobutyric Acid / pharmacokinetics

Substances

  • Carboxylic Acids
  • GABA Agonists
  • Nipecotic Acids
  • Pipecolic Acids
  • gamma-Aminobutyric Acid
  • Tiagabine